KALARIS THERAPEUTICS INC KLRS
COM · Common Stock · CUSIP 482929106
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersBerkeley Heights, NJ
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($169.4k this quarter). Holder counts are more reliable. Shares outstanding: 18.7m as of 2025-11-05, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $8.44.
Trends to Q4 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2025 | 33 |
| Q2 2025 | 31 |
| Q3 2025 | 32 |
| Q4 2025 | 51 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2025 | 13 | 13 |
| Q3 2025 | 18 | 12 |
| Q4 2025 | 32 | 13 |
Biggest buyers
| SAMSARA BIOCAPITAL, LLC | Added | +1.5m |
| RTW INVESTMENTS, LP | New | +1.3m |
| Paradigm Biocapital Advisors LP | New | +700.0k |
| Alyeska Investment Group, L.P. | New | +403.6k |
| Ikarian Capital, LLC | New | +360.0k |
| Siren, L.L.C. | Added | +117.5k |
| ADAR1 Capital Management, LLC | New | +100.0k |
| BOOTHBAY FUND MANAGEMENT, LLC | New | +92.3k |
| VANGUARD GROUP INC | Added | +89.7k |
| RAYMOND JAMES FINANCIAL INC | New | +88.4k |
Biggest sellers
| TANG CAPITAL MANAGEMENT LLC | Sold out | -418.2k |
| Woodline Partners LP | Reduced | -141.1k |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -25.0k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -24.9k |
| Squarepoint Ops LLC | Reduced | -14.8k |
| UBS Group AG | Reduced | -2.6k |
| BlackRock, Inc. | Reduced | -1.9k |
| FEDERATED HERMES, INC. | Sold out | -578 |
| Strengthening Families & Communities, LLC | Sold out | -268 |
| BNP PARIBAS FINANCIAL MARKETS | Reduced | -89 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Samsara BioCapital, L.P. 13D · may seek influence -2.3 pts · filed 2026-05-22 | 54.2% |
| RTW INVESTMENTS, LP 13G · institution new · filed 2026-02-17 | 5.7% |
| Coastlands Capital LP 13G · institution new · filed 2026-10-26 | 5.7% |
Insider purchases and sales in Q4 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2024 | 0 | — | 4 | $77.9k | — |
| Q2 2024 | 0 | — | 4 | $38.6k | — |
| Q3 2024 | 0 | — | 4 | — | — |
| Q4 2024 | 0 | — | 4 | — | — |
| Q1 2025 | 0 | — | 3 | $15.3k | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 0 | — | — |
| Q4 2025 | 1 | $5.0m | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-12-18 | AKKARAJU SRINIVAS +4 Director · By Samsara Opportunity Fund, L.P. | Bought | $5.0m479.8k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q4 2025
| Manager | Shares | Change |
|---|---|---|
| SAMSARA BIOCAPITAL, LLC 11.27% of their portfolio | 12.9m $109.3m | Added +1.5m |
| RTW INVESTMENTS, LP 0.11% of their portfolio | 1.3m $11.0m | New |
| Paradigm Biocapital Advisors LP 0.16% of their portfolio | 700.0k $5.9m | New |
| Siren, L.L.C. 0.11% of their portfolio | 435.8k $3.7m | Added +117.5k |
| Alyeska Investment Group, L.P. 0.01% of their portfolio | 403.6k $3.4m | New |
| Ikarian Capital, LLC 0.39% of their portfolio | 360.0k $3.0m | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 292.8k $2.5m | Added +89.7k |
| Kalehua Capital Management LLC 1.17% of their portfolio | 139.9k $1.2m | First filing |
| Woodline Partners LP 0.00% of their portfolio | 100.0k $844.0k | Reduced -141.1k |
| ADAR1 Capital Management, LLC 0.06% of their portfolio | 100.0k $844.0k | New |
| WHI TRUST Co LLC 0.63% of their portfolio | 97.5k $822.8k | First filing |
| BOOTHBAY FUND MANAGEMENT, LLC 0.02% of their portfolio | 92.3k $778.7k | New |
| RAYMOND JAMES FINANCIAL INC 0.00% of their portfolio | 88.4k $746.4k | New |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 87.8k $740.6k | Reduced -25.0k |
| Redmile Group, LLC 0.05% of their portfolio | 83.0k $700.1k | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 82.6k $697.6k | Added +18.1k |
| 683 Capital Management, LLC 0.06% of their portfolio | 80.6k $680.2k | New |
| MARSHALL WACE, LLP 0.00% of their portfolio | 72.9k $615.1k | Added +58.8k |
| Propel Bio Management, LLC 0.30% of their portfolio | 42.1k $354.9k | New |
| Belpointe Asset Management LLC 0.01% of their portfolio | 40.0k $337.6k | Unchanged |
| Fortis Capital Advisors, LLC 0.05% of their portfolio | 40.0k $337.6k | Unchanged |
| BlackRock, Inc. 0.00% of their portfolio | 38.5k $324.6k | Reduced -1.9k |
| RBF Capital, LLC 0.01% of their portfolio | 34.8k $293.6k | Added +17.4k |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 34.3k $289.5k | Added +11.8k |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 33.1k $279.5k | New |
| OMERS ADMINISTRATION Corp 0.00% of their portfolio | 30.0k $253.2k | New |
| MORGAN STANLEY 0.00% of their portfolio | 27.9k $235.9k | Added +3.0k |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 27.8k $234.3k | New |
| STATE STREET CORP 0.00% of their portfolio | 25.4k $214.5k | Added +2.8k |
| Squarepoint Ops LLC 0.00% of their portfolio | 25.4k $214.1k | Reduced -14.8k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 22.5k $189.9k | Unchanged |
| Simplify Asset Management Inc. 0.00% of their portfolio | 20.1k $169.4k | New |
| NORTHERN TRUST CORP 0.00% of their portfolio | 13.7k $115.2k | New |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 12.9k $108.5k | New |
| Walleye Capital LLC 0.00% of their portfolio | 11.2k $94.7k | New |
| XTX Topco Ltd 0.00% of their portfolio | 10.9k $92.0k | New |
| Keel Point, LLC 0.01% of their portfolio | 10.2k $86.3k | New |
| Connor, Clark & Lunn Investment Management Ltd. 0.00% of their portfolio | 10.2k $85.7k | New |
| Johnson Financial Group, Inc. 0.00% of their portfolio | 10.0k $84.4k | Unchanged |
| FMR LLC 0.00% of their portfolio | 7.8k $65.9k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 6.7k $56.6k | Added +6.5k |
| BARCLAYS PLC 0.00% of their portfolio | 6.1k $51.2k | New |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.03% of their portfolio | 4.0k $33.8k | First filing |
| UBS Group AG 0.00% of their portfolio | 2.7k $22.7k | Reduced -2.6k |
| Fortitude Family Office, LLC 0.00% of their portfolio | 114 $962 | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 113 $1.0k | Added +28 |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 52 $439 | Reduced -89 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 50 $422 | Reduced -50 |
| Parallel Advisors, LLC 0.00% of their portfolio | 49 $414 | Unchanged |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 5 $42 | Reduced -3 |
| CITIGROUP INC 0.00% of their portfolio | 1 $8 | Unchanged |